LivaNova rises on upbeat prelim Q1 revenue; CEO resigns
** Shares of medical device co LivaNova Plc LIVN.O rise
3.31% to $44 after the bell
** Co reports 9% increase in preliminary Q1 2023 revenue to
$263 million, beating Refinitiv IBES estimates of $243.42
million
** Says CEO Damien McDonald has resigned effective
immediately; names its Board Chair William A. Kozy as interim
CEO
** Stock down ~23% YTD
(Reporting by Sriparna Roy)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Livanova
See all newsAIM - Schedule One Update - TEK 4 Holdco Limited
Competition and Mkts - Merger Update: NRG Fleet / Specialist Fleet
LivaNova PLC reports results for the quarter ended June 30 - Earnings Summary
UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlook
Brief: Livanova Demonstrates 84.5% Cumulative Response Rate With Polysync Programming In OSPREY Study